News
8h
HealthDay on MSNUterine Cancer Incidence, Mortality Expected to Increase Through 2050Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...
Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...
1 Introduction Endometrial cancer (EC) ranks as the sixth most common cancer in women worldwide (1), with a lifetime risk of approximately 3% for women. Over the past 30 years, its overall incidence ...
In this open-label, single-arm phase 2 study, women (aged ≥18 years) with recurrent low-grade serous ovarian or peritoneal carcinoma were given selumetinib (50 mg twice daily, orally) until ...
Uterine cancer rates in the United States are expected to climb significantly over the next 25 years, with Black women ...
Uterine cancer incidence is projected to increase an average of 40.8% between 2018 and 2050, with a bulk of the increase expected to occur among Black women. Mortality rates may almost double, ...
Endometrial Cancer Stages After being diagnosed with endometrial cancer, doctors will try to figure out if it has spread and, if so, how far. This process is called staging. The stage of a cancer ...
There were no cases of HER2 positivity among patients with gliomas, sarcomas, small cell lung cancer, gastrointestinal stromal tumors, thyroid carcinoma, uterine sarcoma, thymic carcinoma, and Merkel ...
Individual-level data from 10 cohort and 14 case-control studies from the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 14,069 endometrial cancer cases and 35,312 controls were ...
Dr Ursula A. Matulonis comments on how endometrial cancer treatment is rapidly evolving with new immunotherapies and targeted ...
By contrast, type II EC, which includes uterine serous cancer (USC), clear cell cancer and grade 3 endometrioid carcinoma, typically occurs in older, thinner patients and is not hormone dependent.
Expert Rev Anticancer Ther. 2012;12(1):41-49. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is resistant to cytotoxic chemotherapy and is responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results